Cook Medical’s heritage of innovation began decades ago in 1963 when our founder, Bill Cook, developed the fine art of listening—listening to physicians and identifying what they needed to get patients back to living better lives.
Our heritage of collaborating with physician pioneers has led to a legacy of creative, durability-by-design product development in the aortic clinical specialty.
Aortic disease
Aortic disease is currently an incurable, progressive condition with many complexities, which, left untreated, could be life threatening. Since its inception, Cook Medical has been dedicated to providing a complete aortic therapies program, offering a portfolio of endovascular products and services that assist physicians in the management of aortic disease.
The aorta is the main blood vessel that carries blood from the heart to the rest of the body. An aortic aneurysm occurs when a section of the aorta weakens and begins to bulge. This bulge in the aorta is called an aneurysm. An aneurysm can get larger over time as the walls of the aorta become thinner and stretch like a balloon. When an aneurysm occurs in the part of the aorta that runs through the abdomen, it is called an abdominal aortic aneurysm. When an aneurysm occurs in the part of the aorta that runs through the chest, it is called a thoracic aortic aneurysm. Learn more about the causes, symptoms, and treatment options of aortic aneurysms here.
Learn more about the causes, risks, and treatment options for aortic dissections.
Five key components to providing comprehensive care for patients with aortic dissections. BY SUKGU HAN, MD, MS, AND FERNANDO FLEISCHMAN, MD Aortic dissections make up a significant portion of aortic emergencies that can be rapidly fatal. Time-dependent mortality and morbidity…
A review of this devastating complication including incidence rates after TEVAR for TBAD and the roles of left subclavian artery revascularization, aortic coverage, and cerebrospinal fluid drainage. BY KEAGAN WERNER-GIBBINGS, MS, FRACS, AND BIJAN MODARAI, PhD, FRCS Paraplegia is a…
An overview of advanced imaging methods for the diagnosis and treatment of type B aortic dissection. BY DARREN KLASS, MBChB, MD, MRCS, FCRC, FRCPC Imaging of aortic dissection can be performed both periprocedurally with computed tomography (CT) and intraprocedurally with…
A look at how zone 2 involvement and proximal seal affect TEVAR outcomes for TBAD. BY JOSEPH V. LOMBARDI, MD Zone 2 involvement (ie, disease extending to the aortic segment between the distal margin of left common carotid artery [LCCA]…
A review of the history of the STABLE technique and data from two post hoc comparative analyses comparing these approaches. BY JONATHAN SOBOCINSKI, MD, PhD; DOMINIQUE FABRE, MD; RICHARD AZZAOUI, MD; AND STÉPHAN HAULON, MD, PhD Thoracic endovascular aortic repair…
Recently published data from the STABLE I and STABLE II trials supporting a composite device approach to endovascular treatment of TBAD. BY JOSEPH V. LOMBARDI, MD, AND QING ZHOU, PhD The management of type B aortic dissection (TBAD) has been…
Following FDA approval of Cook Medical’s Zenith Dissection Endovascular System, physicians are beginning to use the new device to improve the lives of and outcomes for patients who suffer from aortic disease. The system gives physicians a less invasive way…
The evidence to guide type B aortic dissection decisions and the aims of repair in acute, subacute, and chronic phases, as well as complicated and uncomplicated cases. BY ATHANASIOS KATSARGYRIS, MD; PABLO MARQUES de MARINO, MD; BALAZS BOTOS, MD; AND…
What are the goals of treatment in each stage of dissection? It is important to differentiate between acute and chronic. If you talk acute, you have to look at your patient, regulate…

By Gustavo S. Oderich, MD The following quote from David Hartley, FIR, remains true today: “It has become clear that not only the technology but also disease progression plays an important role in the durability of endovascular aortic therapy.”1 Endovascular aneurysm…

Jesse Manunga, MD, is a vascular surgeon at Abbott Northwestern Hospital in Minneapolis, Minnesota. Dr. Manunga shares his thoughts on getting experience with FEVAR as a new attending and building a team to support the procedure. How did you start…

Mathew Wooster, MD, is in his fifth and final year of the integrated residency program at the University of South Florida in Tampa. Dr. Wooster shares his experience with FEVAR as a fellow and how it has impacted his job…

Cook Medical mourns the death of a cherished friend, respected vascular surgeon, inventor, and one of the true pioneers of endovascular repair for complex aortic aneurysms, Dr. John Anderson. The following reflection was contributed by John's close friend and colleague,…

Dr. Jason T. Lee, professor of surgery and program director at Stanford University, has a vested interest in helping educate incoming vascular surgery fellows, residents, and young surgeons in practice. Whether he's giving advice on how to run an efficient…
TM Mastracci MD Royal Free London NHS Foundation Trust Assessing the predictive value of a completion angiogram on the long-term durability of EVAR is a task that has only recently been requested of endovascular providers. Now that the endovascular community…
How do we address the chronic nature of aortic disease? That simple question is creating a stir among your vascular colleagues and forcing physicians to ask some tough questions: Should the progression of aortic disease change a physician's approach to…